Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.33B.
ENTERPRISE VALUE (EV)
$3.33B
QuidelOrtho Corporation
Market Cap
$849.97M
Enterprise Value (EV)
$3.33B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| QuidelOrtho Corporation (QDEL) | $849.97M | $3.33B |
| Pacific Biosciences of California, Inc. (PACB)vs › | $846.39M | $1.49B |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $842.91M | $621.40M |
| Beta Bionics, Inc. (BBNX)vs › | $840.62M | $802.81M |
| SL Science Holding Ltd (SLBT)vs › | $860.77M | $859.72M |
| SI-BONE, Inc. (SIBN)vs › | $860.82M | $834.86M |
| Alumis Inc. (ALMS)vs › | $838.63M | $811.36M |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $837.61M | $785.50M |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $863.49M | $842.63M |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $877.53M | $820.33M |
Market Cap
$849.97M
Total Debt
$2.65B
Cash
$169.80M
Enterprise Value
$3.33B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
